Alessandra Pavesio
Chief Tech/Sci/R&D Officer bei Bioventus LLC
Vermögen: 802 386 $ am 31.03.2024
Profil
Alessandra Pavesio is currently the Chief Scientific Officer & Senior Vice President at Bioventus LLC since 2013.
Previously, she held the position of Vice President-Research & Development at Anika Therapeutics, Inc. from 2010 to 2011.
She also served as Vice President-Research & Development at Anika Therapeutics Srl.
Additionally, Ms. Pavesio worked as the Chief Science Officer & Senior Vice President at Bioventus, Inc. from 2013 to 2022.
She is a graduate of the University of Turin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOVENTUS, INC. CLASS A
0,24% | 12.04.2023 | 154 305 ( 0,24% ) | 802 386 $ | 31.03.2024 |
Aktive Positionen von Alessandra Pavesio
| Unternehmen | Position | Beginn |
|---|---|---|
Bioventus LLC
 Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | 05.08.2013 |
Ehemalige bekannte Positionen von Alessandra Pavesio
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVENTUS INC. | Chief Tech/Sci/R&D Officer | 01.12.2022 |
| ANIKA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.12.2011 |
Anika Therapeutics Srl
 Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Part of Anika Therapeutics, Inc., Anika Therapeutics Srl is an Italian joint preservation company that focuses on early intervention orthopedic care. The private company is based in Padua, Italy. Anika offers a range of treatment options for joint preservation. Anika Therapeutics was acquired by Anika Therapeutics, Inc. from Fidia Farmaceutici SpA on December 31, 2009 for $33.87 million. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Alessandra Pavesio
| University of Turin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| BIOVENTUS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Anika Therapeutics Srl
Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Part of Anika Therapeutics, Inc., Anika Therapeutics Srl is an Italian joint preservation company that focuses on early intervention orthopedic care. The private company is based in Padua, Italy. Anika offers a range of treatment options for joint preservation. Anika Therapeutics was acquired by Anika Therapeutics, Inc. from Fidia Farmaceutici SpA on December 31, 2009 for $33.87 million. | Process Industries |
Bioventus LLC
Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Health Technology |
